Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis Journal Article


Authors: Yang, Y. C.; Lu, M. L.; Rao, J. Y.; Wallerand, H.; Cai, L.; Cao, W.; Pantuck, A.; Dalbagni, G.; Reuter, V.; Figlin, R. A.; Belldegrun, A.; Cordon-Cardo, C.; Zhang, Z. F.
Article Title: Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis
Abstract: The impact of the fibroblast growth factor receptor 4 (FGFR4) Gly388Arg polymorphism on bladder cancer is unknown. We found no clear correlations between the FGFR4 genotype and risk of bladder cancer or pathological parameters. Neither the polymorphism nor TP53 mutation status was an independent predictor of prognosis, but they might act jointly on the disease-specific survival of patients. © 2006 Cancer Research.
Keywords: adult; cancer survival; controlled study; aged; middle aged; survival analysis; survival rate; gene mutation; major clinical study; single nucleotide polymorphism; mutation; polymorphism, single nucleotide; cancer risk; genetic association; genotype; bladder cancer; protein p53; urinary bladder neoplasms; survival time; dna mutational analysis; genetic risk; genes, p53; tp53 mutation; fibroblast growth factor receptor 4; receptor, fibroblast growth factor, type 4
Journal Title: British Journal of Cancer
Volume: 95
Issue: 11
ISSN: 0007-0920
Publisher: Nature Publishing Group  
Date Published: 2006-12-04
Start Page: 1455
End Page: 1458
Language: English
DOI: 10.1038/sj.bjc.6603456
PUBMED: 17088904
PROVIDER: scopus
PMCID: PMC2360734
DOI/URL:
Notes: --- - "Cited By (since 1996): 12" - "Export Date: 4 June 2012" - "CODEN: BJCAA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Guido Dalbagni
    325 Dalbagni
  2. Minglan Lu
    23 Lu
  3. Victor Reuter
    1223 Reuter